Brain levels of TNF-␣ increase in many inflammatory conditions, including HIV-1 infection, and may contribute to neurodegenerative processes. The paucity of agents that can selectively and potently block TNF-␣ processing or its receptors has led us to investigate the role of TNF-␣ in chronic neurodegeneration associated with retroviral infection using mice with targeted deletions of the TNF-␣ gene. Infection of wild-type C57BL/6 mice with the LP-BM5 murine leukemia retrovirus mixture leads to the development of a severe immunodeficiency as well as cognitive deficits and neuronal damage. TNF-␣-(-/-) mice infected with LP-BM5 developed a systemic immunopathology indistinguishable in severity from that observed in contemporaneously infected wild-type mice. In contrast, the performance of infected TNF-␣-(-/-) mice in the Y-maze and Morris water maze was not different from that of uninfected TNF-␣-(-/-) mice. The extent of glial activation in the striatum, as indicated by the increase in density of peripheral benzodiazepine receptors, was equivalent in both groups of LP-BM5-infected mice. However, the decrease in striatal MAP-2 expression, a marker of neurodegeneration observed in infected wild-type mice, was not found in infected TNF-␣-(-/-) mice. While the loss of TNF-␣ appeared to have no effect on the course or severity of the central or peripheral immunopathology resulting from LP-BM5 infection, the behavioral and biochemical manifestations were substantially curtailed in the TNF-␣-(-/-) mice. These findings directly support a role for TNF-␣ in the neurodegenerative processes associated with viral infections such as HIV-1.-Iida,
neuronal damage (17) . These lesions are found primarily in the frontal and parietal subregions of the cerebral cortex, the caudate, and putamen (17) . The neurological manifestations of HADC are typically observed in the later stages of infection, when peripheral virus load increases, and CD4-positive cell count declines (18) . Although the spectrum of mechanisms involved in the pathogenesis of HADC remains unclear, one route involves the local production of proinflammatory cytokines including TNF-␣ (15, 19) .
The role of TNF-␣ in the CNS inflammatory processes associated with chronic retroviral infections may be investigated in mice infected with the murine leukemia retrovirus mixture LP-BM5. Mice infected with LP-BM5 develop a profound immunodeficiency, characterized by impaired T-and B-cell responses to mitogens, polyclonal B-cell activation, hypergammaglobulinemia, enhanced susceptibility to secondary infections, and the emergence of lymphoma secondary to the development of anergy (20) . By 3 wk after infection, microglial activation is observed, particularly in the striatum, where highly activated microglial nodules develop (21) . This is followed at 5-wk postinfection by foci of activated astrocytes, particularly in the cortex and striatum. By 8-wk postinfection, biochemical evidence of altered neuronal function is observed, with significant decreases in the levels of neurotransmitters in the striatum, hypothalamus, and cerebral cortex (22) , and alterations in second messenger systems (23, 24) . Histological evidence of neuronal damage in the striatum and cortex is evident by 10 -12-wk postinfection (25) , concurrent with deficits in learning and memory (26, 27) . Administration of pentoxyfylline was previously found to reduce the immunosuppression and neuronal damage developed by LP-BM5-infected mice (28) (Y. Sei and A. S. Basile, unpublished observations). However, it was not clear if this resulted from the ability of pentoxyfylline to alter cAMP phosphodiesterase activity or by suppressing TNF-␣ production. Thus, the role of TNF-␣ in neurodegeneration associated with chronic, retrovirus-induced encephalopathies may be more directly observed in LP-BM5-infected mice with targeted deletions of the TNF-␣ gene.
MATERIALS AND METHODS

Generation of mice with targeted deletions of the TNF-␣ gene
It is important to use the same genetic background of mice, because susceptibility of LP-BM5 virus-induced murine acquired immunodeficiency syndrome (MAIDS) is highly dependent on H2 haplotype (29) . Congenic C57BL/6-TNF-␣-(-/-) and C57BL6 mice were used in the present experiment. Briefly, TNF-KO mice derived from TT2 ES cell line (established from C57BL/6 ϫ CBA/JNCrj Fi blastocyte) were backcrossed to C57BL/6 more than eight generations (30) . Homozygous TNF-␣-(-/-) were obtained by interbreeding of heterozygotes and confirmed by Southern blot analysis for TNF-␣ allele. H2 haplotype of TNF-␣-KO mice was determined to be H2 b , same as C57BL/6, by Dr. Iwakura (Institute for Medical Science, The University of Tokyo). The animals were housed in groups of 10 in a temperature-, humidity-, and light-controlled room (23Ϯ1°C, 50Ϯ5% humidity, 12-h light cycle, starting at 8:00 a.m.), and had free access to food and water, except during the behavioral experiments.
LP-BM5 infection
Mice 4 -6 wk of age were infected by intraperitoneal (i.p.) injection of 0.2 ml of LP-BM5 murine leukemia retrovirus mixture prepared from the G6 clone of chronically infected SC-1 cells (31) . Control groups of mice were injected with 0.2 ml of culture media from uninfected SC-1 cells.
Determination of cell-surface antigens by flow cytometry
The progression of LP-BM5 infection was assessed by flow cytometric analysis of splenocytes labeled with monoclonal antibodies against CD4, CD8, B220, and IL-2R␤ (PharMingen, San Diego, Calif.) (32) . Mean fluorescence intensity and the percentages of antigen-positive and -negative cells were acquired on a flow cytometer (FACS scan, Beckton Dickinson Immunocytometry Systems, Palo Alto, Calif.) and analyzed by LYSIS II software. A total of 10,000 events was analyzed for each antigen.
Splenocyte responses to mitogens
Splenic T-and B-cell responses to mitogens were determined by [ 3 H]-thymidine incorporation (32) . Spleen cells (1 ϫ 10 5 cells/200 l/well) were cultured in 96 well plates with RPMI 1640 medium (supplemented with 10% heat-inactivated fetalbovine serum, 100 units/ml penicillin, and 100 g/ml streptomycin). The splenocytes were then stimulated with either concanavalin A (Con A) (2 g/ml) or lipopolysaccharide (LPS) (10 g/ml) for 48 h, followed by a pulse of [ 3 H]-thymidine (0.2 Ci/well, New England Nuclear, Boston, Mass.). [ 3 H]-Thymidine incorporation into the splenocytes after 12 h of incubation was determined by liquid scintillation counting (32) .
Y-maze test
Spontaneous alternation behavior of mice in a Y-maze, an index of short-term memory, was measured 10 wk after the infection with LP-BM5 (33, 34) . The maze was made of black painted wood, with each arm 40 ϫ 10 ϫ 12 cm (L ϫ W ϫ H), tapering to 3-cm wide at the bottom. The arms converged to a triangular center, 4 cm per side. Each mouse was placed at the end of an arm and allowed to move freely throughout the maze during an 8-min session. The series of arm entries was recorded visually. Alternation was defined as successive entry into the three arms on overlapping triplet sets. The percent alternation was calculated as the ratio of actual alternations to possible alternations (defined as the total number of arm entries minus two), multiplied by 100.
Water maze tests
Water maze tests were performed on mice 12-15 wk after LP-BM5 infection in a pool 1.2 m in diameter constructed from white polypropylene (33, 35) . Water temperature was maintained at 18 Ϯ 1°C.
In the acquisition test, the Plexiglas platform (7 cm in diameter) was submerged 2 cm below the water surface level and maintained in the same location throughout the training period. Swimming paths were tracked with a camera fixed on the ceiling of the experimental room and stored in a computer (TARGET/2 system, Neuroscience, Tokyo). Three starting positions were used pseudorandomly, and the mice were trained to escape onto the submerged platform using three trials per day for 10 days. Each trial lasted 60 s (criterion time). If the mouse found the platform, it was allowed to remain for 20 s before being returned to its home cage. If the mouse was unable to find the platform within 60 s, the training was terminated, and a maximum score of 60 s was assigned.
The probe test was performed one day after the last training trial. In this test, the platform was removed, and each mouse was placed into the pool for 60 s. The total time spent in the quadrant, which had contained the platform during the training trials, was measured.
[ 3 H]PK-11195 binding
After behavioral testing, the mice in all groups were killed according to AAALAC guidelines. The brains were rapidly removed, dissected on wet ice, frozen on dry ice, and stored at -70°C until used. Brain regions were homogenized in 50 volumes of 50 mM Tris HCl buffer, pH 7.4, with a Polytron (30 s, setting 6), washed by centrifugation at 20,000 g for 20 min at 0 -4°C, and the pellet was finally resuspended in 20 volumes of buffer (36) . The assay was performed in duplicate in glass test tubes by incubating 300 l aliquots of homogenate with 50 l of [ 3 H]PK-11195 (0.5-20 nM final concentrations, New England Nuclear) in either the presence or absence of 10 M Ro 5-4864 for the determination of nonspecific binding. Sufficient buffer was added to yield a final volume of 0.5 ml. After 1 h of incubation at room temperature, the assay was terminated by rapid filtration over glass fiber filters (#32, Schleicher and Schuell, Keene, N.H.) pretreated with 0.03% polyethylenimine. The filters were placed into vials with scintillation fluid (Cytoscint, ICN Biomedical, Aurora, Ohio), and the radioactivity retained counted for 2 min (LS6500, Beckman, Fullerton, Calif.). The equilibrium binding constants were determined by data analysis using nonlinear regression techniques (Prism II, GraphPad Software, San Diego, Calif.).
Microtubule-associated protein-2 (MAP-2) immunoblots
Samples were harvested as above and subsequently homogenized by 10 s of sonication in 10 volumes of 0.32 M sucrose/10 mM Tris HCl (pH 7.4) with a protease inhibitor mixture (Calbiochem, San Diego, Calif.) (25) . The homogenates were incubated at 0 -4°C for 30 min, then centrifuged at 20,000 g for 30 min. A 50-l aliquot of supernatant was mixed with 50 l of goat antimouse IgG coupled to agarose beads (Sigma Chemicals, St. Louis, Mo.), and the mixture was shaken for 12 h at 0 -4°C. The beads were removed by centrifugation at 1500 g for 10 min, and the protein content of the supernatant was measured (bicinchoninic acid technique, Pierce Chemicals, Rockford, Ill.). Aliquots of the supernatant containing 35 g of total protein were mixed with denaturing loading buffer and loaded onto 4 -12% gradient polyacrylamide gels. The proteins were separated at 125 volts in constant voltage mode, then transferred to a PVDF membrane, which was incubated with the primary antibody to MAP-2 (1:1000, monoclonal mouse anti-MAP-2, HM2, Sigma) with agitation for 2 days at 0 -4°C. The membranes were rinsed three times in I-Block/phosphate-buffered saline/0.05% TWEEN-20 solution, incubated for 1 h with alkaline phosphatase-conjugated goat anti-mouse IgG (Kirkegaard & Perry Laboratories, Gaithersburg, Md.) for 1 h at 25°C, then developed with an enhanced chemiluminescence protein immunodetection system (Tropix, Bedford, Mass.).
Optical density measurements were made by acquiring digitized images with shading correction. The optical density of each image was determined by converting the gray scale values to absolute optical density units using a calibrated film scale. The data were then presented as percent of O.D. values taken from corresponding control samples run on the same gel.
RESULTS
The extent of LP-BM5 infection and immunosuppression in TNF-␣-(-/-) and wild-type mice at 10-wk postinfection was assessed by weighing the spleen, liver, and lymph nodes, and determining the surface phenotype and proliferative responses of splenocytes in response to Con A and LPS. Marked splenomegaly, hepatomegaly, and lymphoproliferation were observed in both TNF-␣-(-/-) and wild-type mice, with no significant differences between the two groups of infected mice ( Table 1) . Both TNF-␣-(-/-) and wild-type mice showed a significant-98.7% and 98.9%; and 89.8% and 90.5%-suppression of the proliferative response to Con A and LPS, respectively ( Table 1 ). The extent of disease progression in LP-BM5-infected mice was further assessed by determining the percentages of B220-positive, CD4-positive, and interleukin-2 receptor ␤ (IL-2R␤)-positive cells, and the ratio of CD4/CD8-positive cells in infected TNF-␣-(-/-) and wild-type mice at 10-wk postinfection. The percentage of B220-positive B cells decreased 16.8% and 11.9% (PϽ0.05, infected wild-type, infected TNF-␣-(-/-), respectively, Fig. 1A ) after injection, and the percentage of CD4-positive and IL-2R␤-expressing T cells in both infected mouse groups increased 2.7-and 3.8-fold above uninfected mouse levels (PϽ0.05, Fig. 1B) . Moreover, the CD4/CD8-positive cells ratio was increased 3.8-and 2.5-fold in the infected vs. uninfected mouse groups (PϽ0.05, Fig. 1C ). There were no significant differences between the two infected groups of mice in these indices.
The mnemonic abilities of LP-BM5-infected mice were tested by measuring spontaneous alternation behavior in the Y-maze and performance in the Morris water maze. Spontaneous alternation behavior by infected wild-type mice was significantly decreased compared with control (PϽ0.05, Fig. 2A) . However, infected TNF-␣-(-/-) mice showed performance levels that were not different from uninfected TNF-␣-(-/-) mice (Fig. 2A) . The total number of arm entries, an index of exploratory activity, was signifi-cantly decreased by 85.8% in LP-BM5-infected wildtype mice compared with the control wild-type group (PϽ0.01, Fig. 2B ). In contrast, the number of arm entries for both the infected and uninfected TNF-␣-(-/-) groups was decreased relative to uninfected wild-type mice and to the same extent (68.8, 63.7%).
Spatial reference learning and memory were tested in the Morris water maze (37) . The escape latency was significantly prolonged on sessions 5, 7, and 9 of acquisition training in the LP-BM5-infected wild-type mice compared with uninfected wild-type mice (Fig. 3A) . However, there was no difference in escape latency between infected and control TNF-␣-(-/-) mouse groups, nor between these two groups and control wild-type mice. Furthermore, there was no difference among the four groups in their swimming speed (Fig. 3B) . In the probe test, one day after the last training trial in which the platform was removed from the pool, LP-BM5-infected wild-type mice spent 50% less time (PϽ0.01, Fig. 3C ) within the platform-quadrant compared with uninfected wild-type mice. There was no difference in time spent within the platform-quadrant between infected and control TNF-␣-(-/-) groups or control wild-type (Fig. 3C) .
The degree of microglial activation in the striatum and cerebral cortex was assessed in these mice by quantifying the density of peripheral benzodiazepine receptors using [
3 H]PK-11195 binding (38, 39) . The affinity (K d ) of [ 3 H]PK-11195 for the peripheral benzodiazepine receptor was not altered in brain regions from any of the mouse groups (ranging from 1.09Ϯ0.13 to 1.43Ϯ0.14 nM). In contrast, the density (Bmax) of [ 3 H]PK-11195 binding was significantly increased by 1.7-to 2.5-fold in the striata from both infected groups of mice (Fig. 4A) . Although there was a trend toward an increase in the Bmax for [ 3 H]PK-11195 binding to the cerebral cortex in infected mouse groups, the difference between the infected and control wild-type groups did not reach significance (1600Ϯ125 vs. 2300Ϯ500 fmol/mg protein, respectively).
The extent of neuronal dendritic damage was assessed by measuring changes in MAP-2 immunoreactivity (25, 40) . Although cortical MAP-2 immunoreactivity was marginally decreased in LP-BM5-infected wild-type mice, MAP-2 immunoreactivity in the striatum was significantly reduced by 75% of the control levels. In contrast, no changes in striatal or cortical MAP-2 immunoreactivity were observed in infected TNF-␣-(-/-) mice (Fig. 4B, C) .
DISCUSSION
Increased levels of the proinflammatory cytokine TNF-␣ commonly occur in the brain under conditions of chronic inflammation, as in patients with HIV-1 infection and HADC (15, 16, 19) . Evidence suggests that TNF-␣ may contribute to the neuronal and oligodendroglial damage observed in patients with HIV-1 infection and other CNS disorders. This premise is supported by studies of transgenic mice, which chronically overexpress TNF-␣ and develop chronic inflammatory demyelination and severe neurological deficits (10) . Recent studies of the potential neuroprotective actions of TNF-␣ (8, 9) have added to the difficulty in delineating the role(s) that TNF-␣ plays in inflammatory neurodegeneration in vivo. In part, this is because the paucity of agents can selectively block the actions of TNF-␣, and the unexpected role of TNF receptors (TNF-R) in lymphoid organogenesis (41) may influence studies using mice with targeted deletions of the TNF-R. Using mice with a targeted deletion of the TNF-␣ gene coupled with a model of retroviral encephalopathy (LP-BM5 murine leukemia virus) may constitute a more direct route for addressing the role of TNF-␣ in chronic retroviral encephalopathies.
Wild-type mice infected with LP-BM5 typically show a significant increase in the expression of TNF-␣ mRNA by splenocytes, beginning at 4-wk postinfection and steadily increasing throughout the course of the infection (42) . Despite the lack of TNF-␣ in LP-BM5-infected TNF-␣-(-/-) mice, there was no evidence that the course or severity of the infection had been altered, as indicated by the lack of difference in lymphoid organ weight or the proportion of B-and T-cell subpopulations between the infected TNF-␣-(-/-) and wild-type mice. This contrasts with the acceleration of lymphadenopathy observed in lpr mice lacking the TNF-R1 (43) . The lack of change in the course and virulence of the underlying virus infection and accompanying immunopathology, despite the absence of TNF-␣, suggests that the TNF-␣-(-/-) mice have compensated for the loss of immunoregulatory functions directed by TNF-␣. Although the course of the infection was not apparently altered, significant changes in behavior and neurochemistry were exhibited by the infected TNF-␣-(-/-) mice. Typically, substantial decrements in the performance of learning and memory tasks are displayed by wild-type C57BL/6 mice by 8 -10 wk after infection with LP-BM5 (26, 27, 33) . Similarly, perfor- mance of LP-BM5-infected wild-type mice in the Y-maze was measurably impaired in the present study. However, there was absolutely no difference in Y-maze performance between the infected and uninfected TNF-␣-(-/-) mice, whose performance paralleled that of the uninfected wild-type mice. Infected wild-type mice were also slower in learning to escape the Morris water maze, typically showing place acquisition impairment, thigmotaxis and spatial bias for the target quadrant, behaviors consistent with striatal lesions (44) . None of these deficits were observed in LP-BM5-infected TNF-␣-(-/-) mice. Moreover, these performance deficits were not an artifact of impaired motor function, because the swimming speed of all mouse groups was the same. There was some evidence of anxiety displayed by the infected wild-type mice and both groups of TNF-␣-(-/-) mice. Although this may reflect sickness behavior in the infected wild-type group, the expression of anxiety and fearfulness behaviors has been previously observed in mice with targeted deletions of cytokines (45) and other receptor systems (46) . Thus, it is unlikely that the change in arm entries displayed by the TNF-␣-(-/-) groups reflects a neurodegenerative process associated with LP-BM5 infection, nor did it appear to influence performance in the water maze.
The development of spatial learning and memory deficits in LP-BM5-infected mice is preceded by inflammation in the CNS and neurodegeneration (21, 22, 25) . Cytokines and virus proteins in the blood during the initial viremia probably caused the profound microglial activation occurring at 3 wk after infection. Some activated microglia in the striata of infected wild-type mice also show immunohistochemical evidence of TNF-␣ expression (Y. Kustova, personal communication). This microglial activation is followed by localized astrocytosis, increased production of neurotoxins such as glutamate and platelet-activating factor (47, 48) , neurotransmitter loss, and dendritic deafferentation (21, 22, 25) , particularly in the striatum and the cerebral cortex. The activation of microglia in vivo by TNF-␣ can be manifested as an increase in the density of peripheral benzodiazepine receptors (38, 49) . Wildtype mice infected with LP-BM5 showed striatal and cortical microglial activation, as indicated by the increase in Bmax for [ Numerous studies support a dual role for TNF-␣ in orchestrating inflammatory processes, first by enhancing proinflammatory responses and later by acting as an antiinflammatory agent. In the brain, this may be manifested as an initial activation of microglia (11, 50) , suppression of glutamate uptake (14) , and oligodendroglial damage (10), followed by a decreased responsiveness of glutamate receptors and suppression of oxidative stress (8, 9) . This latter, neuroprotective function may be manifested in acute inflammatory episodes (infarcts, seizures, trauma), which can be resolved over a period of weeks or a few months. However, in chronic inflammatory conditions, such as retroviral encephalopathy (e.g., HADC) or encephalomyelopathy (e.g., multiple sclerosis), the resolution phase with its neural protective aspects may be significantly delayed in onset. The present data from an animal model of retroviral encephalopathy support a major role for TNF-␣ in causing or promoting neuronal damage leading to cognitive deficits as a result of such open-ended or recurrent inflammatory processes. Thus, therapeutic modalities, which suppress TNF-␣ expression or activation of its receptors in chronic CNS inflammatory states, may substantially protect neurons and oligodendroglia without significantly curtailing important immune functions.
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